None listed
Conditions
Interventions
Drug : Experimental group take Jaumganghwa-tang granules orally 5g bid for 12 weeks. Control group would not take Jaumganghw-tang but other conditions are same with Experimental group.
Sponsors
Comprehensive & Integrative Medicine Institute
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Breast cancer patients taking tamoxifen more then 6 month with postmenopausal. 2. The ECOG (eastern cooperative oncology group) performance scale 0-2 3. Age: 25-75 4. No disability of cognitive function 5. Patietns who can be possible to follow up during the study 6. Patients whe have signed an approved informed consent
Exclusion criteria
Exclusion criteria: 1. Patients who receive alternative therapy for treatment endometral symptoms. 2. Patients who have a history of hypersensitivity after taking Jaumganghwa-tang granuales. 3. Patients who reveive therapy for treatment gynecological diseases such as endometral cancer, ovarian cancer, endometrial hyperplasia etc. 4. Severe liver or kidney failure at liver and kidney function test. 5. Patients who are not suitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| size and shape of polyps; color of cervix with hysteroscopic;the range or amount of fluid accumulation ; the size and number of cyst | — |
Secondary
| Measure | Time frame |
|---|---|
| vaginal bleeding, vaginal secretions with questionnaires.;blood and hormone test | — |
Countries
Korea, Republic of
Contacts
Public Contactjung jung
Daegu Oriental Hospital of Daegu Haany University
Outcome results
None listed